CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-15 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −3,729 | $10.07 | $38K | 391,686 |
| 2025-03-15 | DIAZ PAUL J President and CEO | Shares withheld for taxes | −30,118 | $10.07 | $303K | 1,009,524 |
| 2025-03-14 | Munk Natalie Chief Accounting Officer | Shares withheld for taxes | −855 | $10.07 | $9K | 49,720 |
| 2025-03-14 | Ancona Margaret SVP, Chief of Staff | Shares withheld for taxes | −3,417 | $10.07 | $34K | 132,878 |
| 2025-03-14 | Solaiman Shereen Chief People Officer | Shares withheld for taxes | −6,060 | $10.07 | $61K | 110,963 |
| 2025-03-14 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −4,390 | $10.07 | $44K | 191,058 |
| 2025-03-14 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −8,544 | $10.07 | $86K | 184,995 |
| 2025-03-14 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −5,847 | $10.07 | $59K | 395,415 |
| 2025-03-14 | Leffler Scott J. Chief Financial Officer | Shares withheld for taxes | −6,217 | $10.07 | $63K | 218,393 |
| 2025-03-14 | Raha Samraat S. Chief Operating Officer | Shares withheld for taxes | −7,649 | $10.07 | $77K | 481,240 |
| 2025-03-14 | DIAZ PAUL J President and CEO | Shares withheld for taxes | −37,564 | $10.07 | $378K | 1,039,642 |
| 2025-03-13 | Munk Natalie Chief Accounting Officer | Grant or award | +4,000 | 50,575 | ||
| 2025-03-13 | Ancona Margaret SVP, Chief of Staff | Grant or award | +54,124 | 136,295 | ||
| 2025-03-13 | Solaiman Shereen Chief People Officer | Grant or award | +63,145 | 117,023 | ||
| 2025-03-13 | Haas Kevin Richard Chief Technology Officer | Grant or award | +54,124 | 195,448 | ||
| 2025-03-13 | Muzzey Dale Chief Scientific Officer | Grant or award | +75,773 | 193,539 | ||
| 2025-03-13 | Fox Jennifer Lynne Chief Legal Officer | Grant or award | +63,145 | 124,916 | ||
| 2025-03-13 | Verratti Mark Chief Commercial Officer | Grant or award | +99,227 | 401,262 | ||
| 2025-03-13 | Leffler Scott J. Chief Financial Officer | Grant or award | +72,165 | 224,610 | ||
| 2025-03-13 | Raha Samraat S. Chief Operating Officer | Grant or award | +216,495 | 488,889 |
Page 7 of 15 · 286 trades